Abstract
Transcriptomic profiling has fundamentally influenced our understanding of cancer pathophysiology and response to therapeutic intervention and has become a relatively routine approach. However, standard protocols are usually low-throughput, single-plex assays and costs are still quite prohibitive. With the evolving complexity of in vitro cell model systems, there is a need for resource-efficient high-throughput approaches that can support detailed time-course analytics, accommodate limited sample availability, and provide the capacity to correlate phenotype to genotype at scale. MAC-seq (multiplexed analysis of cells) is a low-cost, ultrahigh-throughput RNA-seq workflow in plate format to measure cell perturbations and is compatible with high-throughput imaging. Here we describe the steps to perform MAC-seq in 384-well format and apply it to 2D and 3D cell cultures. On average, our experimental conditions identified over ten thousand expressed genes per well when sequenced to a depth of one million reads. We discuss technical aspects, make suggestions on experimental design, and document critical operational procedures. Our protocol highlights the potential to couple MAC-seq with high-throughput screening applications including cell phenotyping using high-content cell imaging.
Key words
- RNA-seq
- Multiplexing
- High-throughput screening
- 3D cell models
- High-content imaging
Equal author contribution: Xiang Mark Li and David Yoannidis
Equal senior author contribution: Gisela Mir Arnau, Timothy Semple and Kaylene J. Simpson
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ye C, Ho DJ, Neri M et al (2018) DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery. Nat Commun 9:4307
Li J, Ho DJ, Henault M et al (2021) DRUG-seq provides unbiased biological activity readouts for drug discovery. Biorxiv 2021(06):07.447456
Alpern D, Gardeux V, Russeil J et al (2019) BRB-seq: ultra-affordable high-throughput transcriptomics enabled by bulk RNA barcoding and sequencing. Genome Biol 20:71
Moyerbrailean GA, Davis GO, Harvey CT et al (2015) A high-throughput RNA-seq approach to profile transcriptional responses. Sci Rep 5:14976
Todorovski I, Feran B, Fan Z et al (2022) RNA decay defines the therapeutic response to transcriptional perturbation in cancer. Biorxiv 2022(04):06.487057
Kong IY, Trezise S, Light A et al (2022) Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysis. Cell Death Differ 29:2519–2530
So J, Lewis AC, Smith LK et al (2022) Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia. EMBO Mol Med 14:e15203
Wang Y, Jeon H (2022) 3D cell cultures toward quantitative high-throughput drug screening. Trends Pharmacol Sci 43:569–581
Szymański P, Markowicz M, Mikiciuk-Olasik E (2011) Adaptation of high-throughput screening in drug discovery—toxicological screening tests. Int J Mol Sci 13:427–452
Hughes RE, Elliott RJR, Dawson JC et al (2021) High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need. Cell Chem Biol 28:338–355
Choo N, Ramm S, Luu J et al (2021) High-throughput imaging assay for drug screening of 3D prostate cancer organoids. Slas Discov 26:1107–1124
Ramm S, Vary R, Gulati T et al (2022) High-throughput live and fixed cell imaging method to screen Matrigel-embedded organoids. Organoids 2:1–19
Acknowledgements
We thank members of the Molecular Genomics Core facility and Victorian Centre for Functional Genomics for their valuable input into the development of these methodologies. The Victorian Centre for Functional Genomics (KJS) is funded by the Australian Cancer Research Foundation (ACRF), Phenomics Australia, through funding from the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) program and the Peter MacCallum Cancer Centre Foundation. This project has been supported by specific project funding through Phenomics Australia (KJS) and separate Peter MacCallum Foundation grants to GMA and SR.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Li, X.M. et al. (2023). MAC-Seq: Coupling Low-Cost, High-Throughput RNA-Seq with Image-Based Phenotypic Screening in 2D and 3D Cell Models. In: Jenkins, B.J. (eds) Inflammation and Cancer. Methods in Molecular Biology, vol 2691. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3331-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3331-1_22
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3330-4
Online ISBN: 978-1-0716-3331-1
eBook Packages: Springer Protocols